Presentation Title

A-1 Benzothiazoles as Novel Hybrid Anti-Invasion Agent Against Glioblastoma

Presenter Status

Graduate Student, Andrews University

Second Presenter Status

Instructor, Andrews University

Third Presenter Status

Associate Professor, Andrews University

Preferred Session

Oral Session

Start Date

26-10-2018 3:00 PM

End Date

26-10-2018 3:15 PM

Presentation Abstract

This presentation discusses the progress we are making regarding the efficacy of our novel synthesized hybrid benzothiazole compounds against a rare and extremely lethal brain cancer called glioblastoma. This cancer, for which there is currently no effective treatment, has been in the news recently as the cause of death for former U.S. Senator John McCain. The presentation will cover the purpose, design, and strategy of the project and the work that has been accomplished to date.

Acknowledgments

Andrews University Department Biology/Chemistry and Biochemistry, Andrews University Faculty Grants, Andrews University Graduate Student Grants in Aid of Research

This document is currently not available here.

Share

COinS
 
Oct 26th, 3:00 PM Oct 26th, 3:15 PM

A-1 Benzothiazoles as Novel Hybrid Anti-Invasion Agent Against Glioblastoma

This presentation discusses the progress we are making regarding the efficacy of our novel synthesized hybrid benzothiazole compounds against a rare and extremely lethal brain cancer called glioblastoma. This cancer, for which there is currently no effective treatment, has been in the news recently as the cause of death for former U.S. Senator John McCain. The presentation will cover the purpose, design, and strategy of the project and the work that has been accomplished to date.